IL17A and cancer: Also, IL-17 has been shown to enhance angiogenesis by encouraging cancer cells to release vascular endothelial growth factor (VEGF) via the signal Transducer and activator of Transcription 3 (STAT3)/girdin-like protein (GIV) signaling pathway in NSCLC tissue [560].